---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-001051"
form_type: "8-K"
ticker: "BPTH"
cik: "0001133818"
company_name: "BIO-PATH HOLDINGS, INC."
filed_at: "2025-02-18T23:59:59+00:00"
generated_at: "2026-05-26T14:17:51.055748+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Nasdaq delists Bio-Path Holdings for failure to meet equity requirement

## Summary
- Nasdaq notified Bio-Path on Feb 14, 2025; trading suspended at open on Feb 19, 2025.
- Company failed to regain compliance with $2.5M minimum stockholders’ equity by Jan 31, 2025.
- Common stock expected to trade on OTC Markets under symbol BPTH starting Feb 19, 2025.
- Company does not intend to request a review of the Panel's delisting decision.

## SEC filing metadata
- accession: 0001558370-25-001051
- form_type: 8-K
- ticker: BPTH
- cik: 0001133818
- company_name: BIO-PATH HOLDINGS, INC.
- filed_at: 2025-02-18T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133818/000155837025001051/0001558370-25-001051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133818/000155837025001051/bpth-20250214x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-001051
- JSON: https://secwatch.observer/filing/0001558370-25-001051.json
- Plain text: https://secwatch.observer/filing/0001558370-25-001051.txt

## Key facts
- Listing & Compliance Notices
  BIO-PATH HOLDINGS, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: February 14, 2025, the Nasdaq Stock Market LLC (“Nasdaq”) notified Bio-Path Holdings, Inc. (the “Company”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common stock, par value $0.001 per share (“Common Stock”), and that trading of the Company’s Common Stock will be suspended at the open of trading on February 19, 2025. ​ As previously reported, on November 19, 2024, the Company was granted an extension until January 31, 2025 from the Panel to demonstrate compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed issuers to maintain minimum stoc
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133818/000155837025001051/0001558370-25-001051-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.